Global Companion Diagnostics Market Research Report 2026(Status and Outlook)
Description
Report Overview
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient’s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Companion Diagnostics market size was estimated at USD 5106.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Companion Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Companion Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Companion Diagnostics market.
Global Companion Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostics Market
Overview of the regional outlook of the Companion Diagnostics Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient’s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Companion Diagnostics market size was estimated at USD 5106.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Companion Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Companion Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Companion Diagnostics market.
Global Companion Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostics Market
Overview of the regional outlook of the Companion Diagnostics Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
146 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Companion Diagnostics
- 1.2 Key Market Segments
- 1.2.1 Companion Diagnostics Segment by Type
- 1.2.2 Companion Diagnostics Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Companion Diagnostics Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Companion Diagnostics Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Companion Diagnostics Product Life Cycle
- 3.3 Global Companion Diagnostics Sales by Manufacturers (2020-2025)
- 3.4 Global Companion Diagnostics Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Companion Diagnostics Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Companion Diagnostics Market Competitive Situation and Trends
- 3.8.1 Companion Diagnostics Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Companion Diagnostics Industry Chain Analysis
- 4.1 Companion Diagnostics Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Companion Diagnostics Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Companion Diagnostics Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Companion Diagnostics Market
- 5.7 ESG Ratings of Leading Companies
- 6 Companion Diagnostics Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Companion Diagnostics Sales Market Share by Type (2020-2025)
- 6.3 Global Companion Diagnostics Market Size by Type (2020-2025)
- 6.4 Global Companion Diagnostics Price by Type (2020-2025)
- 7 Companion Diagnostics Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Companion Diagnostics Market Sales by Application (2020-2025)
- 7.3 Global Companion Diagnostics Market Size (M USD) by Application (2020-2025)
- 7.4 Global Companion Diagnostics Sales Growth Rate by Application (2020-2025)
- 8 Companion Diagnostics Market Sales by Region
- 8.1 Global Companion Diagnostics Sales by Region
- 8.1.1 Global Companion Diagnostics Sales by Region
- 8.1.2 Global Companion Diagnostics Sales Market Share by Region
- 8.2 Global Companion Diagnostics Market Size by Region
- 8.2.1 Global Companion Diagnostics Market Size by Region
- 8.2.2 Global Companion Diagnostics Market Size by Region
- 8.3 North America
- 8.3.1 North America Companion Diagnostics Sales by Country
- 8.3.2 North America Companion Diagnostics Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Companion Diagnostics Sales by Country
- 8.4.2 Europe Companion Diagnostics Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Companion Diagnostics Sales by Region
- 8.5.2 Asia Pacific Companion Diagnostics Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Companion Diagnostics Sales by Country
- 8.6.2 South America Companion Diagnostics Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Companion Diagnostics Sales by Region
- 8.7.2 Middle East and Africa Companion Diagnostics Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Companion Diagnostics Market Production by Region
- 9.1 Global Production of Companion Diagnostics by Region(2020-2025)
- 9.2 Global Companion Diagnostics Revenue Market Share by Region (2020-2025)
- 9.3 Global Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Companion Diagnostics Production
- 9.4.1 North America Companion Diagnostics Production Growth Rate (2020-2025)
- 9.4.2 North America Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Companion Diagnostics Production
- 9.5.1 Europe Companion Diagnostics Production Growth Rate (2020-2025)
- 9.5.2 Europe Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Companion Diagnostics Production (2020-2025)
- 9.6.1 Japan Companion Diagnostics Production Growth Rate (2020-2025)
- 9.6.2 Japan Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Companion Diagnostics Production (2020-2025)
- 9.7.1 China Companion Diagnostics Production Growth Rate (2020-2025)
- 9.7.2 China Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Roche Holdings
- 10.1.1 Roche Holdings Basic Information
- 10.1.2 Roche Holdings Companion Diagnostics Product Overview
- 10.1.3 Roche Holdings Companion Diagnostics Product Market Performance
- 10.1.4 Roche Holdings Business Overview
- 10.1.5 Roche Holdings SWOT Analysis
- 10.1.6 Roche Holdings Recent Developments
- 10.2 Abbott Laboratories
- 10.2.1 Abbott Laboratories Basic Information
- 10.2.2 Abbott Laboratories Companion Diagnostics Product Overview
- 10.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
- 10.2.4 Abbott Laboratories Business Overview
- 10.2.5 Abbott Laboratories SWOT Analysis
- 10.2.6 Abbott Laboratories Recent Developments
- 10.3 Thermo Fisher Scientific
- 10.3.1 Thermo Fisher Scientific Basic Information
- 10.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
- 10.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
- 10.3.4 Thermo Fisher Scientific Business Overview
- 10.3.5 Thermo Fisher Scientific SWOT Analysis
- 10.3.6 Thermo Fisher Scientific Recent Developments
- 10.4 Agilent Technologies
- 10.4.1 Agilent Technologies Basic Information
- 10.4.2 Agilent Technologies Companion Diagnostics Product Overview
- 10.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
- 10.4.4 Agilent Technologies Business Overview
- 10.4.5 Agilent Technologies Recent Developments
- 10.5 Life Technologies
- 10.5.1 Life Technologies Basic Information
- 10.5.2 Life Technologies Companion Diagnostics Product Overview
- 10.5.3 Life Technologies Companion Diagnostics Product Market Performance
- 10.5.4 Life Technologies Business Overview
- 10.5.5 Life Technologies Recent Developments
- 10.6 GE Healthcare
- 10.6.1 GE Healthcare Basic Information
- 10.6.2 GE Healthcare Companion Diagnostics Product Overview
- 10.6.3 GE Healthcare Companion Diagnostics Product Market Performance
- 10.6.4 GE Healthcare Business Overview
- 10.6.5 GE Healthcare Recent Developments
- 10.7 Agendia
- 10.7.1 Agendia Basic Information
- 10.7.2 Agendia Companion Diagnostics Product Overview
- 10.7.3 Agendia Companion Diagnostics Product Market Performance
- 10.7.4 Agendia Business Overview
- 10.7.5 Agendia Recent Developments
- 10.8 Qiagen
- 10.8.1 Qiagen Basic Information
- 10.8.2 Qiagen Companion Diagnostics Product Overview
- 10.8.3 Qiagen Companion Diagnostics Product Market Performance
- 10.8.4 Qiagen Business Overview
- 10.8.5 Qiagen Recent Developments
- 10.9 Genomic Health
- 10.9.1 Genomic Health Basic Information
- 10.9.2 Genomic Health Companion Diagnostics Product Overview
- 10.9.3 Genomic Health Companion Diagnostics Product Market Performance
- 10.9.4 Genomic Health Business Overview
- 10.9.5 Genomic Health Recent Developments
- 10.10 Myriad Genetics
- 10.10.1 Myriad Genetics Basic Information
- 10.10.2 Myriad Genetics Companion Diagnostics Product Overview
- 10.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
- 10.10.4 Myriad Genetics Business Overview
- 10.10.5 Myriad Genetics Recent Developments
- 10.11 Advanced Cell Diagnostics
- 10.11.1 Advanced Cell Diagnostics Basic Information
- 10.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
- 10.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
- 10.11.4 Advanced Cell Diagnostics Business Overview
- 10.11.5 Advanced Cell Diagnostics Recent Developments
- 10.12 Danaher
- 10.12.1 Danaher Basic Information
- 10.12.2 Danaher Companion Diagnostics Product Overview
- 10.12.3 Danaher Companion Diagnostics Product Market Performance
- 10.12.4 Danaher Business Overview
- 10.12.5 Danaher Recent Developments
- 10.13 Applied Proteomics
- 10.13.1 Applied Proteomics Basic Information
- 10.13.2 Applied Proteomics Companion Diagnostics Product Overview
- 10.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
- 10.13.4 Applied Proteomics Business Overview
- 10.13.5 Applied Proteomics Recent Developments
- 11 Companion Diagnostics Market Forecast by Region
- 11.1 Global Companion Diagnostics Market Size Forecast
- 11.2 Global Companion Diagnostics Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Companion Diagnostics Market Size Forecast by Country
- 11.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
- 11.2.4 South America Companion Diagnostics Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Companion Diagnostics by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Companion Diagnostics Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2026-2035)
- 12.1.2 Global Companion Diagnostics Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Companion Diagnostics by Type (2026-2035)
- 12.2 Global Companion Diagnostics Market Forecast by Application (2026-2035)
- 12.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
- 12.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
